Postoperative Analgesic Effectiveness of the Modified Thoracoabdominal Nerve Block Through a Perichondrial Approach in Total Laparoscopic Hysterectomy
MTAPA-TLH
Retrospective Evaluation of the Effect of the Modified Thoracoabdominal Nerve Block Through a Perichondrial Approach on Postoperative Analgesic Consumption in Patients Undergoing Total Laparoscopic Hysterectomy
1 other identifier
observational
60
1 country
1
Brief Summary
This single-center retrospective cohort study evaluated the effect of the modified thoracoabdominal nerves block through a perichondrial approach (M-TAPA) on postoperative analgesia in patients undergoing elective total laparoscopic hysterectomy. Medical records of 60 patients who underwent surgery at Tekirdag Namik Kemal University Faculty of Medicine Hospital between December 25, 2023 and December 25, 2024 were retrospectively reviewed. Patients who received bilateral ultrasound-guided M-TAPA block were compared with patients who received standard general anesthesia and systemic analgesia without M-TAPA block. The primary outcome was cumulative tramadol consumption during the first 24 postoperative hours. Secondary outcomes included postoperative Visual Analog Scale (VAS) pain scores at predefined time points, rescue analgesic requirements, postoperative nausea and vomiting, Quality of Recovery-15 (QoR-15) scores, and block-related complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2024
CompletedFirst Submitted
Initial submission to the registry
July 23, 2026
CompletedFirst Posted
Study publicly available on registry
July 31, 2026
CompletedJuly 31, 2026
July 1, 2026
1 year
July 23, 2026
July 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cumulative tramadol consumption during the first 24 postoperative hours
Total tramadol consumption delivered by patient-controlled analgesia (PCA) during the first 24 postoperative hours.
During the first 24 postoperative hours
Secondary Outcomes (5)
Postoperative pain intensity
At 0, 6, 12, and 24 hours after surgery
Quality of recovery (QoR-15)
At 24 hours after surgery
Rescue analgesic requirements
During the first 24 hours after surgery
Postoperative nausea and vomiting
During the first 24 hours after surgery
Block-related complications
During the first 24 postoperative hours
Study Arms (2)
M-TAPA Group
Patients who underwent elective total laparoscopic hysterectomy under general anesthesia and received bilateral ultrasound-guided modified thoracoabdominal nerves block through a perichondrial approach (M-TAPA) in addition to standard perioperative analgesia.
Control Group
Patients who underwent elective total laparoscopic hysterectomy under general anesthesia and received standard perioperative analgesia without modified thoracoabdominal nerves block through a perichondrial approach (M-TAPA).
Interventions
Bilateral ultrasound-guided modified thoracoabdominal nerves block through a perichondrial approach using 20 mL of 0.25% bupivacaine on each side (total volume: 40 mL), performed before surgical incision as part of multimodal analgesia.
Eligibility Criteria
Female patients aged 18-65 years with ASA physical status I-II who underwent elective total laparoscopic hysterectomy at Tekirdag Namik Kemal University Faculty of Medicine Hospital between December 25, 2023, and December 25, 2024.
You may qualify if:
- Female patients aged 18 to 65 years.
- American Society of Anesthesiologists (ASA) physical status I or II.
- Undergoing elective total laparoscopic hysterectomy under general anesthesia.
- Availability of complete perioperative and postoperative medical records.
You may not qualify if:
- Neurological disorders affecting pain perception.
- Coagulopathy or bleeding disorders.
- Known allergy to local anesthetics.
- Chronic opioid use before surgery.
- Body mass index (BMI) greater than 35 kg/m².
- Incomplete medical records.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tekirdag Namik Kemal University Faculty of Medicine Hospital
Tekirdağ, Tekirdağ, 59030, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Anesthesiology and Reanimation
Study Record Dates
First Submitted
July 23, 2026
First Posted
July 31, 2026
Study Start
December 25, 2023
Primary Completion
December 25, 2024
Study Completion
December 25, 2024
Last Updated
July 31, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share